Amyotrophic lateral sclerosis: lessons in trial design from recent trials

This publication has 20 references indexed in Scilit:

• Rilazole for amyotrophic lateral sclerosis
  Drug and Therapeutics Bulletin, 1997
• A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS
  BMJ, 1996
• Dose-ranging study of riluzole in amyotrophic lateral sclerosis
  The Lancet, 1996
• A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis
  Neurology, 1996
• Continuous response variable trial design in motor neuron disease: long term treatment with a TRH analogue (RX77368).
  Journal of Neurology, Neurosurgery & Psychiatry, 1995
• A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
  New England Journal of Medicine, 1994
• Insulin-like Growth Factor-I: Potential for Treatment of Motor Neuronal Disorders
  Experimental Neurology, 1993
• Noninvasive Ventilation: Does it Work, for Whom, and How?
  American Review of Respiratory Disease, 1993
• Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors.
  The Journal of cell biology, 1990
• The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
  Medical Care, 1981